Kuwait-based North African Holding Company (NorAH) CEO Emad Anwar Al-Saleh said Sunday the establishment of a joint venture for cancer drugs with Algeria's Saidal Group was yet another step towards boosting of Kuwait investments in the north African country. Al-Saleh was speaking to KUNA after the signing ceremony of an agreement to establish the joint venture. "This partnership can provide the Algerian market with a variety of products including pharmaceuticals and primarily cancer drugs," he said. The joint venture will pave way for further projects that Kuwait Projects Company (KIPCO) Holding planned to establish in Algeria, he said. This venture, added Al-Saleh, would bolster Kuwait-Algerian cooperation in different sectors.